Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith. Alkem Laboratories Ltd - 539523 - Application For Reclassification Under Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In terms of Regulation 31A of SEBI (LODR) Regulations, 2015 and pursuant to the receipt of approval from the shareholders of the Company through Postal Ballot on 05th April, 2024, the Company has submitted the application to BSE Limited and The National Stock Exchange of India Limited for the Reclassification of certain members of the Promoter Group of the Company. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith. Alkem Laboratories Ltd - 539523 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAlkem Laboratories Ltd 2CIN NO.L00305MH1973PLC174201 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Manish Narang Designation: President Legal Company Secretary and Compliance Officer EmailId: manishnarang@alkem.com Name of the Chief Financial Officer: Nitin Agrawal Designation: President Finance and Chief Financial Officer EmailId: nitin.agrawal@alkem.com Date: 23/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith. Alkem Laboratories Ltd - 539523 - Reply To BSE Email - Additional Details Required Under SEBI Circular Dated July 13, 2023, For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Please find attached herewith our response with respect to your email dated 12th April, 2024. Alkem Laboratories Ltd - 539523 - Compliances- Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024.
In terms of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Certificate received from Practising Company Secretary for the year ended 31st March, 2024. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Compliance Certificate For The Period Ended March, 2024.
With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly signed by the Compliance Officer and the authorized representative of Link Intime India Pvt Ltd (RTA) for the year ended 31st March, 2024. Kindly take the same on your records. Alkem Laboratories Ltd - 539523 - Reply To BSE Limited - Outcome Of The 49Th Annual General Meeting Of The Company.
With reference to the captioned subject, please find attached herewith the updated proceedings of 49th Annual General Meeting (AGM) of the Company for including the conclusion time of the AGM. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.